B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Carteolol

299 PubMed studies analyzed ยท 52 RCTs ยท Evidence Score: 48.9

Research Domains

Carteolol has been studied across 20 research domains including ๐Ÿ‘๏ธ Vision & Eye, โค๏ธ Cardiovascular, ๐Ÿ”ฌ Inflammation, ๐Ÿ”ฌ Oncology, ๐Ÿง  Focus & Attention. The primary research focus is ๐Ÿ‘๏ธ Vision & Eye with 36% of studies addressing this area.

Loading evidence profile...

This evidence profile for Carteolol is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.